First Time Loading...
P

Pear Therapeutics Inc
NASDAQ:PEAR

Watchlist Manager
Pear Therapeutics Inc
NASDAQ:PEAR
Watchlist
Price: 0.0077 USD -15.38% Market Closed
Updated: May 8, 2024

Pear Therapeutics Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pear Therapeutics Inc
Operating Income Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
P
Pear Therapeutics Inc
NASDAQ:PEAR
Operating Income
-$117.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Operating Income
$429.3m
CAGR 3-Years
4%
CAGR 5-Years
14%
CAGR 10-Years
27%
Inspire Medical Systems Inc
NYSE:INSP
Operating Income
-$40.3m
CAGR 3-Years
11%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Operating Income
$12.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Operating Income
$125.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Operating Income
-$25.2m
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pear Therapeutics Inc's Operating Income?
Operating Income
-117.2m USD

Based on the financial report for Dec 31, 2022, Pear Therapeutics Inc's Operating Income amounts to -117.2m USD.

What is Pear Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 1Y
-11%

Over the last year, the Operating Income growth was -11%.